Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia-Reference-Cited by-同舟云学术

Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia

Published:2023-04 Issue:4 Volume:11 Page:1317-1319.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Delcros Quentin,Taillé Camille,Vallée Alexandre,Brun Anne-Laure,Chenivesse Cécile,Couture Priscille,Daboussi Selsabil,Guilleminault Laurent,Juster Fabienne,Kahn Jean-Emmanuel,Lefèvre Guillaume,Liozon Eric,Magnan Antoine,Meireles Sylvie,Moulis Guillaume,Puech Corentin,Tcherakian Colas,Traclet Julie,Uzunhan Yurdagül,Cottin Vincent,Groh Matthieu

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference8 articles.

1. Steroid alternatives for managing eosinophilic lung diseases;Delcros;Expert Opin Orphan Drugs,2021

2. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis;Wechsler;N Engl J Med,2017

3. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial;Roufosse;J Allergy Clin Immunol,2020

4. Benralizumab for PDGFRA-negative hypereosinophilic syndrome;Kuang;N Engl J Med,2019

5. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?;Marchand;Eur Respir J,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healing chronic idiopathic eosinophilic pneumonia using mepolizumab alone without corticosteroids;Wiener klinische Wochenschrift;2024-08-08

2. Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program;Journal of Leukocyte Biology;2024-07-06

3. The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience;Allergy and Asthma Proceedings;2024-07-01

4. Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities;Journal of Leukocyte Biology;2024-03-08

5. Maladie associée aux IgG4 : une maladie protéiforme aux manifestations thoraciques fréquentes;Revue des Maladies Respiratoires;2023-11